SALT LAKE CITY, Sept. 2, 2010 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced that Adrian Hobden, Ph.D., President and Chief Executive Officer, is scheduled to present an overview of the Company at two upcoming conferences in New York, NY: the Rodman & Renshaw Global Investment Conference, to be held September 12-15, 2010; and the UBS Global Life Sciences Conference, taking place September 20-22, 2010.
